Harmony Biosciences Holdings, Inc. (HRMY) return on equity (ROE)

Return on equity · fiscal 2025
18.2%

Harmony Biosciences Holdings, Inc. (HRMY) earned a return on equity of 18.2% in fiscal 2025 (the year ended December 31, 2025). That is 3.8 percentage points lower than the 22.1% of fiscal 2024. Figures as of 18 Nov 2026, 12:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
18.2%
Change on fiscal 2024
−3.8 pts
Highest on record
45.0%fiscal 2022
Lowest on record
-38.0%fiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Harmony Biosciences Holdings, Inc. return on equity (ROE), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was 45.0% in fiscal 2022 and the lowest -38.0% in fiscal 2020. The fiscal 2025 figure is higher than in 20% of the 5 earlier fiscal years on record, whose median is 22.1%.

History · 6 fiscal years

Return on equity by fiscal year

Harmony Biosciences Holdings, Inc. return on equity (ROE), year by year

Harmony Biosciences Holdings, Inc. (HRMY) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202518.2% 3.8 pts down
202422.1% 5.5 pts down
202327.6% 17.5 pts down
202245.0% 26.5 pts up
202118.5% 56.6 pts up
2020-38.0%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on HRMY

Harmony Biosciences Holdings, Inc., figure by figure

Harmony Biosciences Holdings, Inc. (HRMY) overview: price, valuation and scorecard

Harmony Biosciences Holdings, Inc. return on equity (ROE): questions and answers

What is Harmony Biosciences Holdings, Inc.'s return on equity?

Harmony Biosciences Holdings, Inc. (HRMY) earned a return on equity of 18.2% in fiscal 2025 (the year ended December 31, 2025). That is 3.8 percentage points lower than the 22.1% of fiscal 2024.

Is Harmony Biosciences Holdings, Inc.'s return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 20% of the 5 earlier fiscal years on record, whose median is 22.1%.

What are the highest and lowest return on equity figures on record for Harmony Biosciences Holdings, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was 45.0% in fiscal 2022 and the lowest -38.0% in fiscal 2020.

How is Harmony Biosciences Holdings, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For Harmony Biosciences Holdings, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Harmony Biosciences Holdings, Inc. (HRMY) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/HRMY/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.